-
-
-
n this issue: Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions.
-
Eleven heroin users in Northern England and Scotland, as well as a possible twelfth, have been diagnosed with anthrax infection; five have died.
-
Nearly half of the world's population live in malaria-endemic geographic regions, and more than one million African children die of malaria each year. Vaccine development continues.
-
A longitudinal study of hospitalized WNV patients in Houston was initiated in 2002. A total of 112 patients remain in the cohort.
-
Click here for the February 2010 Clinical Briefs in Primary Care supplement
-
Malaria is one of the most important diagnostic considerations in febrile returned travelers and can be fatal if not appropriately diagnosed and treated.
-
In October 2009, the US FDA approved Cervarix, a bivalent vaccine containing the oncogenic HPV types 16 and 18, for the prevention of cervical cancer and precancerous lesions in females ages 10 years through 25 years.
-
In this prospective, randomized, placebo-controlled trial from the Netherlands, 6,771 patients were screened on admission to the hospital for the presence of Staphylococcus aureus nasal colonization using real-time PCR. Of those, 1,251 patients were positive for S. aureus and 917 were included in the intent-to-treat analysis.